Contact
/
Home
/
About
Team
Portfolio
Exit History
News
About
Team
Portfolio
Exit History
News
Advent Life Sciences
Advent Life Sciences
Page 12 of 25
<< Start
< Prev
7
8
9
10
11
12
13
14
15
16
Next >
End >>
22.09.2015
Artax Biopharma Funded to Clinically Develop Breakthrough Oral Therapies for Autoimmune Diseases
Press Release
21.09.2015
Positive Topline Results Announced from Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure’s Novel AAV5-Based Gene Therapy
Press Release
13.07.2015
EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CARDIAQ
Press Release
10.07.2015
Success of Cellnovo’s IPO with €31.6 million raised on Euronext in Paris
Press Release
24.04.2015
BIOCARTIS RAISES EUR 100 MILLION IN SUCCESSFUL INITIAL PUBLIC OFFERING
Press Release
06.03.2015
Aura Biosciences Closes $21M Series B Financing
Press Release
04.03.2015
Macrolide Pharmaceuticals, Inc. Raises $22 Million in Series A Financing
Press Release
21.01.2015
Versartis Announces Pricing of Follow - On Offering
Press Release
21.01.2015
The American Hospital Association Exclusively Endorses Vestex® Active Barrier Apparel from Vestagen Technical Textiles, Inc.
Press Release
09.01.2015
Versartis Initiates Global Phase 3 Study of VRS-317 in Children With Growth Hormone Deficiency
Press Release
©2022 Advent Life Sciences